BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 27783990)

  • 1. Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth.
    Yang B; Zhang S; Wang Z; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C
    Oncotarget; 2016 Nov; 7(48):79515-79525. PubMed ID: 27783990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410.
    Sun WL; Kang T; Wang YY; Sun JP; Li C; Liu HJ; Yang Y; Jiao BH
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30498093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis.
    Shang Z; Zhao J; Zhang Q; Cao C; Tian S; Zhang K; Liu L; Shi L; Yu N; Yang S
    J Biol Chem; 2019 Jun; 294(25):9844-9857. PubMed ID: 31073027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA H19 regulates the development of gliomas through the Wnt/β-catenin signaling pathway.
    Guan N; Wang R; Guo WS; Lai YJ; Zhang YD; Cheng YY
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4243-4253. PubMed ID: 31173296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
    Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival.
    Schwickart M; Huang X; Lill JR; Liu J; Ferrando R; French DM; Maecker H; O'Rourke K; Bazan F; Eastham-Anderson J; Yue P; Dornan D; Huang DC; Dixit VM
    Nature; 2010 Jan; 463(7277):103-7. PubMed ID: 20023629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of transcriptional coactivator TAZ in gliomas.
    Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
    Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAGI3 negatively regulates Wnt/β-catenin signaling and suppresses malignant phenotypes of glioma cells.
    Ma Q; Yang Y; Feng D; Zheng S; Meng R; Fa P; Zhao C; Liu H; Song R; Tao T; Yang L; Dai J; Wang S; Jiang WG; He J
    Oncotarget; 2015 Nov; 6(34):35851-65. PubMed ID: 26452219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expressions of Wnt/β-catenin pathway-related components in brainstem gliomas.
    Wu W; Tian Y; Wan H; Song Y; Li J; Zhang L
    Can J Neurol Sci; 2013 May; 40(3):355-60. PubMed ID: 23603171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of TET1 Promotes Glioma Cell Proliferation and Invasion by Targeting Wnt/
    Ji J; You Q; Zhang J; Wang Y; Cheng J; Huang X; Zhang Y
    Anal Cell Pathol (Amst); 2021; 2021():8980711. PubMed ID: 34926132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RBM5 inhibits tumorigenesis of gliomas through inhibition of Wnt/β-catenin signaling and induction of apoptosis.
    Jiang Y; Sheng H; Meng L; Yue H; Li B; Zhang A; Dong Y; Liu Y
    World J Surg Oncol; 2017 Jan; 15(1):9. PubMed ID: 28061901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AKT/GSK-3β/β-catenin signaling pathway participates in erythropoietin-promoted glioma proliferation.
    Tang Z; Yang G; Wang X; Chen F; Liao Z; Zhang Z; Liu Z; Zeng W; Fang M; Wang W; Sun X; Huo G
    J Neurooncol; 2020 Sep; 149(2):231-242. PubMed ID: 32909117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway.
    Yu X; Wang M; Wu J; Han Q; Zhang X
    J Exp Clin Cancer Res; 2019 Jan; 38(1):40. PubMed ID: 30691485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presenilin1 exerts antiproliferative effects by repressing the Wnt/β-catenin pathway in glioblastoma.
    Yang W; Wu PF; Ma JX; Liao MJ; Xu LS; Xu MH; Yi L
    Cell Commun Signal; 2020 Feb; 18(1):22. PubMed ID: 32046730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-603 promotes glioma cell growth via Wnt/β-catenin pathway by inhibiting WIF1 and CTNNBIP1.
    Guo M; Zhang X; Wang G; Sun J; Jiang Z; Khadarian K; Yu S; Zhao Y; Xie C; Zhang K; Zhu M; Shen H; Lin Z; Jiang C; Shen J; Zheng Y
    Cancer Lett; 2015 Apr; 360(1):76-86. PubMed ID: 25681036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAX3 Promotes Proliferation of Human Glioma Cells by WNT/β-Catenin Signaling Pathways.
    Liang X; Dong Z; Bin W; Dekang N; Xuhang Z; Shuyuan Z; Liwen L; Kai J; Caixing S
    J Mol Neurosci; 2019 May; 68(1):66-77. PubMed ID: 30826985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-catenin is regulated by USP9x and mediates resistance to TRAIL-induced apoptosis in breast cancer.
    Ouyang W; Zhang S; Yang B; Yang C; Zhang J; Zhou F; Xie C
    Oncol Rep; 2016 Feb; 35(2):717-24. PubMed ID: 26717875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA Linc00320 inhibits glioma cell proliferation through restraining Wnt/β-catenin signaling.
    Tian S; Liu W; Pan Y; Zhan S
    Biochem Biophys Res Commun; 2019 Jan; 508(2):458-464. PubMed ID: 30503496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
    Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L
    Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner.
    Wiese M; Walther N; Diederichs C; Schill F; Monecke S; Salinas G; Sturm D; Pfister SM; Dressel R; Johnsen SA; Kramm CM
    Oncotarget; 2017 Apr; 8(16):27300-27313. PubMed ID: 28460484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.